In a comment (1) on our article in Diabetes Care (2), Dr. Philip Home posits that the association of severe hypoglycemic events with other medical conditions and the use of diagnoses from hospitalized patients could explain the high event rate noted in our study compared with other reports based in the ambulatory care setting. Home correctly notes that use of secondary hypoglycemia diagnoses and diagnoses from inpatient hospital admissions may overestimate the rate of severe hypoglycemia as the primary cause of visits in emergency departments or that result in hospital admission. To clarify, our analyses relied on only primary or principal diagnosis codes. In addition, only 20% of our events included only inpatient diagnosis codes. Although our event rate is higher than those reported in clinical trials (1.4–1.6 events per 100 person-years (2) vs. 0.3–1.0 events per 100 person-years [35]), there are several potential explanations for higher hypoglycemia rates in community settings. We hope further work will develop additional methods for minimizing misclassification in hypoglycemia definitions and will clarify factors that increase hypoglycemia risk in community settings.

Duality of Interest. E.B.S. was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant K23DK099237. E.R.S. served as a consultant for Sanofi. No other potential conflicts of interest relevant to this article were reported.

1.
Home
PD
.
Comment on Pathak et al
.
Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005–2011
.
Diabetes Care
2016
;
39
:
363
370
(Letter). Diabetes Care 2017;40:e25. DOI: 10.2337/dc16-0527
.
2.
Pathak
RD
,
Schroeder
EB
,
Seaquist
ER
, et al.;
SUPREME-DM Study Group
.
Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005–2011
.
Diabetes Care
2016
;
39
:
363
370
3.
ADVANCE Collaborative Group
,
Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
.
N Engl J Med
2008
;
358
:
129
139
4.
Gerstein
HC
,
Miller
ME
,
Byington
RP
, et al.;
Action to Control Cardiovascular Risk in Diabetes Study Group
.
Effects of intensive glucose lowering in type 2 diabetes
.
N Engl J Med
2008
;
358
:
2545
2559
5.
ORIGIN Trial Investigators
.
Predictors of nonsevere and severe hypoglycemia during glucose-lowering treatment with insulin glargine or standard drugs in the ORIGIN trial
.
Diabetes Care
2015
;
38
:
22
28
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.